Published in Appl Immunohistochem Mol Morphol on June 01, 2005
Evaluation of the relationship between c-Kit expression and mean platelet volume in classic Kaposi's sarcoma. An Bras Dermatol (2016) 0.77
[Primary sarcomas and sarcoma metastases in the liver: morphological and molecular aspects]. Pathologe (2006) 0.76
Biomarkers of HIV-associated Cancer. Biomark Cancer (2014) 0.75
Intestinal Kaposi's sarcoma may mimic gastrointestinal stromal tumor in HIV infection. World J Gastroenterol (2007) 0.75
Characterization of c-Kit expression and activation in KSHV-infected endothelial cells. Virology (2009) 0.75
[Pathology along the liver sinusoids: endothelial and perisinusoidal findings]. Pathologe (2008) 0.75
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med (2010) 36.78
Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1. Nat Med (2005) 4.83
HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol (2008) 3.21
Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat Genet (2004) 2.47
Increased expression of stem cell markers in malignant melanoma. Mod Pathol (2006) 2.39
Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma. Blood (2009) 2.07
HIV-associated monoclonal gammopathy: a retrospective analysis of 25 patients. Clin Infect Dis (2006) 1.88
Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage. Am J Surg Pathol (2005) 1.74
The growing problem of non-AIDS-defining malignancies in HIV. Curr Opin Oncol (2006) 1.69
AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy. Oncologist (2005) 1.69
The rising challenge of non-AIDS-defining cancers in HIV-infected patients. Clin Infect Dis (2012) 1.62
Kaposi sarcoma in unusual locations. BMC Cancer (2008) 1.60
CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma. J Am Acad Dermatol (2003) 1.57
Expert review of non-Hodgkin's lymphomas in a population-based cancer registry: reliability of diagnosis and subtype classifications. Cancer Epidemiol Biomarkers Prev (2004) 1.55
Human immunodeficiency virus-associated prostate cancer: clinicopathological findings and outcome in a multi-institutional study. BJU Int (2008) 1.55
Human immunodeficiency virus-associated hemophagocytosis with iron-deficiency anemia and massive splenomegaly. Clin Infect Dis (2003) 1.54
Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma. PLoS Pathog (2009) 1.53
Time for oncologists to opt in for routine opt-out HIV testing? JAMA (2010) 1.53
Primary esophageal carcinoma in the era of highly active antiretroviral therapy. Arch Intern Med (2010) 1.52
Gene expression profiles of cutaneous B cell lymphoma. J Invest Dermatol (2003) 1.51
Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus. Cancer Res (2005) 1.48
Prognostic factors in primary cutaneous anaplastic large cell lymphoma: characterization of clinical subset with worse outcome. Arch Dermatol (2009) 1.46
Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation. J Infect Dis (2009) 1.46
Thrombotic complications in patients infected with HIV in the era of highly active antiretroviral therapy: a case series. Clin Infect Dis (2004) 1.44
Spectrum of human papillomavirus-related dysplasia and carcinoma of the anus in HIV-infected patients. AIDS Read (2005) 1.43
HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease. Clin Infect Dis (2008) 1.42
The Kaposi's sarcoma-associated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoter. J Virol (2002) 1.41
Images in HIV/AIDS. Sweet syndrome and syphilis in an HIV-infected person. AIDS Read (2008) 1.39
Follicular malignant melanoma: a case report of a metastatic variant and review of the literature. J Am Acad Dermatol (2011) 1.39
HIV infection masquerading as monoclonal gammopathy of undetermined significance. N Engl J Med (2003) 1.39
HHV8 is not limited to Kaposi's sarcoma. Mod Pathol (2005) 1.38
Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998. Cancer (2003) 1.35
Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study. J Clin Oncol (2005) 1.31
Imatinib-induced regression of AIDS-related Kaposi's sarcoma. J Clin Oncol (2004) 1.29
Pevonedistat (MLN4924), a First-in-Class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study. Br J Haematol (2015) 1.29
Management of AIDS-related Kaposi's sarcoma. Lancet Oncol (2007) 1.26
A phase I first-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomas. Clin Cancer Res (2012) 1.21
High resolution anoscopy findings for men who have sex with men: inaccuracy of anal cytology as a predictor of histologic high-grade anal intraepithelial neoplasia and the impact of HIV serostatus. Clin Infect Dis (2004) 1.20
Cutaneous plasmacytosis: A report of five cases with immunohistochemical evaluation for HHV-8 expression. Am J Dermatopathol (2006) 1.19
Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study. J Clin Oncol (2002) 1.16
Pegylated liposomal doxorubicin as second-line therapy in the treatment of patients with advanced classic Kaposi sarcoma: a retrospective study. Cancer (2008) 1.10
Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma. Blood (2009) 1.09
Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration. Clin Lung Cancer (2010) 1.08
Breast cancer in HIV positive women: a report of four cases and review of the literature. Cancer Invest (2003) 1.08
Human immunodeficiency virus-associated adenocarcinoma of the colon: clinicopathologic findings and outcome. Clin Colorectal Cancer (2009) 1.08
HIV-associated multicentric Castleman's disease. Am J Hematol (2008) 1.07
Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populations. Int J Cancer (2008) 1.07
Isolation and mutational analysis of circulating tumor cells from lung cancer patients with magnetic sifters and biochips. Lab Chip (2014) 1.07
Effects of chemotherapy in AIDS-associated non-Hodgkin's lymphoma on Kaposi's sarcoma herpesvirus DNA in blood. J Clin Oncol (2009) 1.06
T-cell clonality analysis in biopsy specimens from two different skin sites shows high specificity in the diagnosis of patients with suggested mycosis fungoides. J Am Acad Dermatol (2007) 1.04
Kaposi sarcoma of the musculoskeletal system: a review of 66 patients. Cancer (2007) 1.04
Staging accuracy in mycosis fungoides and sezary syndrome using integrated positron emission tomography and computed tomography. Arch Dermatol (2006) 1.03
Human Immunodeficiency Virus-associated anaplastic large cell lymphoma. Leuk Lymphoma (2010) 1.03
Reactive eccrine syringofibroadenoma arising in peristomal skin: An unusual presentation of a rare lesion. J Am Acad Dermatol (2008) 1.03
Diffuse high intensity PD-L1 staining in thymic epithelial tumors. J Thorac Oncol (2015) 1.02
Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma. J Acquir Immune Defic Syndr (2011) 1.02
Reproductive factors in Hodgkin's disease in women. Am J Epidemiol (2003) 1.01
Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi's sarcoma: a multicenter study. J Invest Dermatol (2008) 1.01
Evolving spectrum and incidence of non-AIDS-defining malignancies. Curr Opin HIV AIDS (2009) 0.99
HIV-associated bladder cancer: a case series evaluating difficulties in diagnosis and management. BMC Urol (2009) 0.99
A phase I study of ultra low dose interleukin-2 and stem cell factor in patients with HIV infection or HIV and cancer. Clin Cancer Res (2006) 0.99
A6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial. Gynecol Oncol (2005) 0.99
Lack of human herpesvirus 8 and Epstein-Barr virus in Kikuchi's histiocytic necrotizing lymphadenitis. Hum Pathol (2003) 0.99
Case of fatal sickle cell intrahepatic cholestasis despite use of exchange transfusion in an African-American patient. J Natl Med Assoc (2006) 0.98
Frequency of occult high-grade squamous intraepithelial neoplasia and invasive cancer within anal condylomata in men who have sex with men. Clin Infect Dis (2010) 0.98
Telaprevir-related dermatitis. JAMA Dermatol (2013) 0.98
AIDS-related Kaposi's sarcoma of the gastrointestinal tract. J Clin Oncol (2010) 0.97
High-resolution array-based comparative genomic hybridization for distinguishing paraffin-embedded Spitz nevi and melanomas. Diagn Mol Pathol (2004) 0.96
Phase II trial of imatinib in AIDS-associated Kaposi's sarcoma: AIDS Malignancy Consortium Protocol 042. J Clin Oncol (2013) 0.95
Accuracy of biopsy sampling for subtyping basal cell carcinoma. J Am Acad Dermatol (2011) 0.95
Palisaded neutrophilic and granulomatous dermatitis associated with limited systemic sclerosis. J Am Acad Dermatol (2007) 0.95
Adenomatoid tumors of the female and male genital tracts: a clinicopathological and immunohistochemical study of 44 cases. Mod Pathol (2009) 0.94
Reasons for a deficit of breast cancer among HIV-infected patients. J Clin Oncol (2004) 0.94
Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047. J Clin Oncol (2012) 0.94
AIDS-related non-Hodgkin lymphoma: still a problem in the era of HAART. AIDS Read (2004) 0.93
Quantitative, architectural analysis of immune cell subsets in tumor-draining lymph nodes from breast cancer patients and healthy lymph nodes. PLoS One (2010) 0.93
Cutaneous involvement by angioimmunoblastic T-cell lymphoma: a unique histologic presentation, mimicking an infectious etiology. J Cutan Pathol (2006) 0.92
Use of in vivo confocal microscopy in malignant melanoma: an aid in diagnosis and assessment of surgical and nonsurgical therapeutic approaches. Arch Dermatol (2004) 0.92
Social class and risk of Hodgkin's disease in young-adult women in 1988-94. Int J Cancer (2002) 0.92
New approaches in the treatment of HIV/AIDS - focus on maraviroc and other CCR5 antagonists. Ther Clin Risk Manag (2008) 0.91
Double-blinded, placebo-controlled trial of green tea extracts in the clinical and histologic appearance of photoaging skin. Dermatol Surg (2005) 0.91
Higher prevalence of monoclonal gammopathy of undetermined significance in African Americans than whites--the unknown role of underlying HIV infection. J Natl Med Assoc (2006) 0.91
"Nevus/melanocytoma/melanoma": that which we call a rose by any other name would smell as sweet. Arch Pathol Lab Med (2012) 0.91
Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura. Clin Infect Dis (2009) 0.91
Altered local and systemic immune profiles underlie lymph node metastasis in breast cancer patients. Int J Cancer (2012) 0.89
Smoking and Hodgkin lymphoma risk in women United States. Cancer Causes Control (2004) 0.89
Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008). Cancer Immunol Immunother (2015) 0.89
PRC2/EED-EZH2 complex is up-regulated in breast cancer lymph node metastasis compared to primary tumor and correlates with tumor proliferation in situ. PLoS One (2012) 0.88
Expression of neurotrophin receptor Trk-C in nevi and melanomas. J Cutan Pathol (2003) 0.87
Granulomatous and suppurative dermatitis at interferon alfa injection sites: report of 2 cases. J Am Acad Dermatol (2002) 0.87
Molecular and clinical assessment in the treatment of AIDS Kaposi sarcoma with valproic Acid. Clin Infect Dis (2009) 0.87
Dermatologic changes induced by repeated Ixodes scapularis bites and implications for prevention of tick-borne infection. Vector Borne Zoonotic Dis (2009) 0.87
Rapamycin with antiretroviral therapy in AIDS-associated Kaposi sarcoma: an AIDS Malignancy Consortium study. J Acquir Immune Defic Syndr (2012) 0.87
Morphologic and immunophenotypic evidence of in-situ Kaposi's sarcoma. BMC Clin Pathol (2006) 0.86